Catalyst Pharmaceuticals (CPRX) Amortizatization of Intangibles (2023 - 2026)
Catalyst Pharmaceuticals (CPRX) posted Amortizatization of Intangibles of $135000.0 for Q1 2026, up 16.38% on a QoQ basis from $116000.0 in Q4 2025, and up 125.0% year-over-year from $60000.0 in Q1 2025.
Catalyst Pharmaceuticals (CPRX) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
Catalyst Pharmaceuticals' Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at $135000.0 for Q1 2026.
- Quarterly Amortizatization of Intangibles rose 125.0% year-over-year to $135000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $425000.0 (down 59.45% YoY) and the FY2025 annual result came in at $350000.0, down 58.08% from the prior year.
- Amortizatization of Intangibles was $135000.0 for Q1 2026 at Catalyst Pharmaceuticals, up from $116000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $1.1 million in Q3 2024 and bottomed at -$1.1 million in Q3 2023.
- A 4-year average of $0.0 and a median of $60000.0 in 2025 frame the typical range for Amortizatization of Intangibles.
- Peak annual rise in Amortizatization of Intangibles reached 197.44% in 2025, while the deepest fall reached 91.14% in 2025.
- Catalyst Pharmaceuticals' Amortizatization of Intangibles stood at -$174000.0 in 2023, then jumped by 122.41% to $39000.0 in 2024, then soared by 197.44% to $116000.0 in 2025, then advanced by 16.38% to $135000.0 in 2026.
- Business Quant data shows CPRX's Amortizatization of Intangibles at $135000.0 in Q1 2026, $116000.0 in Q4 2025, and $96000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn | 135,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 135,000.00 |
| Mar 31, 2026 | 135,000.00 |
| Dec 31, 2025 | 116,000.00 |
| Dec 31, 2025 | 116,000.00 |
| Sep 30, 2025 | 96,000.00 |
| Sep 30, 2025 | 96,000.00 |
| Jun 30, 2025 | 78,000.00 |
| Jun 30, 2025 | 78,000.00 |
| Mar 31, 2025 | 60,000.00 |
| Mar 31, 2025 | 60,000.00 |
| Dec 31, 2024 | 39,000.00 |
| Dec 31, 2024 | 39,000.00 |
| Sep 30, 2024 | 1.08 Mn |
| Sep 30, 2024 | 1.08 Mn |
| Jun 30, 2024 | -134,000.00 |
| Jun 30, 2024 | -134,000.00 |
| Mar 31, 2024 | -153,000.00 |
| Mar 31, 2024 | -153,000.00 |
| Dec 31, 2023 | -174,000.00 |
| Dec 31, 2023 | -174,000.00 |